Drug Design and Development 2013

download Drug Design and Development 2013

of 10

Transcript of Drug Design and Development 2013

  • 8/18/2019 Drug Design and Development 2013

    1/10

    PHARMACEUTICALPHARMACEUTICAL

    CHEMISTRY RESEARCHCHEMISTRY RESEARCHPROJECTS 2013PROJECTS 2013

    ;;

  • 8/18/2019 Drug Design and Development 2013

    2/10

    RESEARCH AREASRESEARCH AREAS

    1. Drug Design & Discovery1. Drug Design & Discovery

     (Dr. J. Joubert & Prof. S. Malan)(Dr. J. Joubert & Prof. S. Malan)

    2. Drug Synthesis & Biological2. Drug Synthesis & Biologicalvaluation !gainst "athogenicvaluation !gainst "athogenic

    Microbes (Dr. J. Joubert & Prof S. Malan)Microbes (Dr. J. Joubert & Prof S. Malan)

    #. Phytoche$istry (Prof P. agles)#. Phytoche$istry (Prof P. agles)

  • 8/18/2019 Drug Design and Development 2013

    3/10

    1. Drug design and Dis!"er# $1. Drug design and Dis!"er# $

    %eur!&r!'e'i"e C!(&!unds%eur!&r!'e'i"e C!(&!unds

    Drug %esignDrug %esign Biological activityBiological activityan% "hysical'che$ical "ro"erties.an% "hysical'che$ical "ro"erties.

    Dr. J. Joubert, Prof. S.F. Malan and co-workers

  • 8/18/2019 Drug Design and Development 2013

    4/10

    Targe's )!r %eur!&r!'e'i!nTarge's )!r %eur!&r!'e'i!n

    alciu$ ho$eostasesalciu$ ho$eostases

      alciu$ channelsalciu$ channels  *MD! rece"tor channels*MD! rece"tor channels

    n+y$e syste$s involve% inn+y$e syste$s involve% inneuro%egenerationneuro%egeneration

    ,-i%ative casca%e,-i%ative casca%e

    *,S an% M!,'B.*,S an% M!,'B.

    NOS-reaction

  • 8/18/2019 Drug Design and Development 2013

    5/10

    Resear* +i'*in drug designResear* +i'*in drug design

      ea% co$"oun%sea% co$"oun%s he$ical synthesishe$ical synthesis

    %rugs in use%rugs in use *e/ co$"oun%s fro$*e/ co$"oun%s fro$

    "lants"lants  Molecular $o%elingMolecular $o%eling

      Synthesis an%Synthesis an%characteri+ationcharacteri+ation

      Biological activityBiological activity In vitroIn vitro

    In vivoIn vivo

    ,*0

  • 8/18/2019 Drug Design and Development 2013

    6/10

    Protein $o%elingProtein $o%eling  ece"tor ece"tor   n+y$e fit n+y$e fit

    33igan%fit4igan%fit4

    33Doc5ing4Doc5ing4

    M!,eu,ar (!de,ingM!,eu,ar (!de,ing

  • 8/18/2019 Drug Design and Development 2013

    7/10

    S#n'*esis andS#n'*esis and

    C*ara'erisa'i!nC*ara'erisa'i!n*02

    1

    2

    0

    06*02

    (1) !$anta%ine 1 7 0 2 7 0(2) Me$antine 1 7 06 2 7 06

    (6) i$anta%ine

    R

    O

    O

    O

    OHO O

    O O

    (a)

    O

    (i) Dean-Strark(ii) NaBH4 /methanol-THF

    (ii) HO(CH2)2OH(iv) Huang-Minlon(v) NH2OH, NaBH4

    NH

    OH

    (vi) N2CHCO2Et(vii) F3B.OEt

    (viii) NaCl, DMSO,H2O, N2

    O

    O O

    1; R = benzylamine

    2; R = phenyhydrazyne

    3a; R = 4-nitrobenzylamine3b; R = 3-nitrobenzylamine3c; R = 2-nitrobenzylamine

    4a; R = 4-methoxybenzylamine4b; R = 3-methoxybenzylamine4c; R = 2-methoxybenzylamine

    5a; R = 3-methylpyridine5b; R = 4-methylpyridine

    9; R = phenylethylamine

    (ix) 30%H2O2,

    SeO2,t-Butanol

    12

    R1

    8

    R1

    11

    6 7R = benzylamine

    Synthesis and

    characeterization withNM, MS and !.

      7 *,2  7 *02  7 *(208)2  7 *(609)2  7 *(#0:)2

    *

    ,0

    7 *,2 7 *02 7 *(208)2 7 *(609)2 7 *(#0:)2

    *

    ,0

    7 *,2 7 *02 7 *(208)2 7 *(609)2 7 *(#0:)2

    *

    ,0

      7 *,2  7 *02  7 *(208)2  7 *(609)2  7 *(#0:)2

    *

    ,

    7 *,2 7 *02 7 *(208)2 7 *(609)2 7 *(#0:)2

    *

    ,

    7 *,2 7 *02 7 *(208)2 7 *(609)2 7 *(#0:)2

    *

    ,

  • 8/18/2019 Drug Design and Development 2013

    8/10

    -i!,!gia, e"a,ua'i!n -i!,!gia, e"a,ua'i!n In "i'r! / InIn "i'r! / In

    "i"! "i"! 

    ';< '#< '2< < 2<

    '

  • 8/18/2019 Drug Design and Development 2013

    9/10

    2. S#n'*esis !) %!"e,H#rid2. S#n'*esis !) %!"e,H#rid

    M!,eu,es / -i!,!gia, E"a,ua'i!n $M!,eu,es / -i!,!gia, E"a,ua'i!n $

    Ma,aria and Dengue )e"er Ma,aria and Dengue )e"er 

    =nhibitory !ctivity=nhibitory !ctivity

     esistance reversal in Microorganis$sesistance reversal in Microorganis$s

    Microsco"ic evaluationMicrosco"ic evaluation

    Molecular Stu%iesMolecular Stu%ies

  • 8/18/2019 Drug Design and Development 2013

    10/10

    3. PHYTOCHEMISTRY Pr!) Eag,es3. PHYTOCHEMISTRY Pr!) Eag,es

    Phytoche$istry is the stu%y of "hytoche$icals "ro%uce%Phytoche$istry is the stu%y of "hytoche$icals "ro%uce%

    in "lants %escribing the isolation "urification i%entification an%in "lants %escribing the isolation "urification i%entification an%

    structure of the large nu$ber of secon%ary $etabolic co$"oun%sstructure of the large nu$ber of secon%ary $etabolic co$"oun%s

    foun% in "lants.foun% in "lants.

    Techniques commonly used in the field of phytochemistryTechniques commonly used in the field of phytochemistry

    ??@hin layer chro$atogra"hy (@)@hin layer chro$atogra"hy (@)

    ??Ael (colu$n chro$atogra"hy)Ael (colu$n chro$atogra"hy)

    ??0igh "erfor$ance of liui% chro$atogra"hy (0P)0igh "erfor$ance of liui% chro$atogra"hy (0P) ??Aas chro$atogra"hy (A)Aas chro$atogra"hy (A)

    ??Mass s"ectro$etryMass s"ectro$etry